Liquid biopsies have emerged as a versatile diagnostic solution,
especially for cases when conventional (invasive) diagnostic tests are
inconclusive or when the clinical condition is related to an organ that is not
amenable to biopsy access
Roots Analysis is pleased to announce the publication of its recent study,
titled, “Liquid Biopsy and Other Non-Invasive
Cancer Diagnostics Market
(3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs,
ctDNA, cfDNA, Exosomes and Other Biomarkers.”
The report features
an extensive study of the current market landscape, offering an informed
opinion on the likely adoption of this approach over the next decade. It features
an in-depth analysis, highlighting the capabilities of various stakeholders
engaged in this domain. In addition to other elements, the study includes:
§
A detailed review of
the overall landscape of the non-invasive cancer diagnostics market.
§
An analysis of the
various partnerships pertaining to non-invasive cancer diagnostics, which have
been established between 2016 and 2019.
§
An analysis of the
investments made in companies engaged in the development of non-invasive cancer
diagnostics.
§
An analysis of the
initiatives of big pharma players.
§
A detailed
acquisition target analysis.
§
Elaborate profiles of
the key players engaged in this domain.
§
A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)
§
Type of Tumor Marker
§
ctDNA
§
cfDNA
§
CTCs
§
Exosomes
§
Others
§
Application
§
Diagnosis / Early
Diagnosis
§
Patient Monitoring
§
Recurrence Monitoring
§
Target Cancer
Indication
§
Breast Cancer
§
Lung Cancer
§
Colorectal Cancer
§
Prostate Cancer
§
Bladder Cancer
§
Melanoma
§
Gastric Cancer
§
Pancreatic Cancer
§
Ovarian Cancer
§
Others
§
End Users
§
Hospitals
§
Research Institutes
§
Others
§
Key Geographical Regions
Press Release: Variation 1 (Format 2)
§
North America
§
Europe
§
Asia-Pacific
§
Rest of the World
Key companies covered in the report:
§
Amoy Diagnostics
§
DiaCarta
§
HaploX Biotechnology
§
NeoGenomics
§
QIAGEN
§
Swift Biosciences
§
Sysmex Inostics
§
Thermo Fisher Scientific
For more information,
please click on the following link:
https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
Other recent
offerings
1.
DNA-Encoded
Libraries: Platforms and Services Market
2.
Antibody
Discovery: Services and Platforms Market (2nd Edition), 2018-2028
3.
In
Silico / Computer-Aided Drug Discovery Services
Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid,
Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery,
Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug
Discovery, Interface Based Drug Discovery Approaches)
1.
Cancer Biomarkers
Market:
Focus on TMB, MSI / MMR and TILs Testing, 2019-2030
About Roots Analysis
Roots Analysis is one
of the fastest growing market research companies, sharing fresh and independent
perspectives in the bio-pharmaceutical industry. The in-depth research,
analysis and insights are driven by an experienced leadership team which has
gained many years of significant experience in this sector. If you’d like help
with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis
Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
